Cochrane Evidence Synthesis and Methods ►

Botulinum toxin type A formulations in focal dystonias

To compare the clinical efficacy, safety and immunogenicity of Botulinum Toxin Type A formulations (Dysport® and Botox®) in the treatment of focal dystonias.

This is a protocol.

Health topics:

Neurology > Movement disorders > Dystonia

Published:

21 January 2009

Authors:

Costa J, Ferreira J, Freire R, Coelho MM, Sampaio C

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Costa J, Ferreira J, Freire R, Coelho MM, Sampaio C. Botulinum toxin type A formulations in focal dystonias. Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD004313. DOI: 10.1002/14651858.CD004313.pub2